跳至主要内容
临床试验/CTRI/2022/09/045566
CTRI/2022/09/045566尚未招募未知

A randomised study to assess the role of adjuvant IgM enriched Intravenous Immunoglobulin on mortality of Very Low Birth Weight new-borns with sepsis

Dr Rinku Saini0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All Very Low Birth Weight newborns (1-1.499 kg) with sepsis
  • 2.Prior written informed consent signed by the legal guardian

排除标准

  • 1.Very Low Birth Weight new-borns with congenital anomalies & TORCH infections
  • 2.Refusal for consent
  • 3.Very low birth weight newborns <1 kg birth weight (ELBW ââ?¬â?? extremely low birth weight newborns)
  • 4.Severely ill septic VLBW newborns (with shock and/or requiring mechanical ventilation).

研究者

发起方
Dr Rinku Saini

相似试验

A study to know the efficacy of adjuvant IgM in... | 临床试验